{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:59:32Z","timestamp":1773291572458,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.clineuro.2012.02.046","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T14:51:26Z","timestamp":1331909486000},"page":"1204-1205","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacokinetic considerations in the repositioning of mefloquine for treatment of progressive multifocal leukoencephalopathy"],"prefix":"10.1016","volume":"114","author":[{"given":"Remington Lee","family":"Nevin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2012.02.046_bib0005","unstructured":"Hirayama M, Nosaki Y, Matsui K, Terao S, Kuwayama M, Tateyama H, et al. Efficacy of mefloquine to progressive multifocal leukoencephalopathy initially presented with parkinsonism. Clin Neurol Neurosurg, doi:org\/10.1016\/j.clineuro.2011.12.010, in press."},{"key":"10.1016\/j.clineuro.2012.02.046_bib0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.2009.190652","article-title":"Mefloquine in the treatment of progressive multifocal leukoencephalopathy","volume":"82","author":"Gofton","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0015","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.2169\/internalmedicine.49.3227","article-title":"Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant","volume":"49","author":"Kishida","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0020","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archneurol.2010.157","article-title":"Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis","volume":"67","author":"Schr\u00f6der","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1073858409356594","article-title":"Progressive multifocal leukoencephalopathy: what's new?","volume":"16","author":"Focosi","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.NT.0000397959.27386.55","article-title":"News from the AAN Annual Meeting: Malaria Drug Fails to Fulfill Promise in PML","volume":"11","author":"Friedman","year":"2011","journal-title":"Neurol Today"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0035","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro","volume":"53","author":"Brickelmaier","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0040","first-page":"353","article-title":"Single-dose kinetics of mefloquine in Brazilian male subjects","volume":"65","author":"de Souza","year":"1987","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0045","first-page":"238","article-title":"Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man","volume":"37","author":"Schwartz","year":"1980","journal-title":"Acta Trop"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0035-9203(93)90036-P","article-title":"Steady state pharmacokinetics of mefloquine in long-term travellers","volume":"87","author":"Pennie","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00228-006-0247-3","article-title":"Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment","volume":"63","author":"Charles","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0090-9556(25)05714-9","article-title":"Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090","volume":"3","author":"Mu","year":"1975","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0065","first-page":"654","article-title":"The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-alpha-(2-piperidyl)-4-quinolinemethanol hydrochloride","volume":"6","author":"Rozman","year":"1978","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0379-0738(94)90376-X","article-title":"Mefloquine distribution in postmortem cases","volume":"68","author":"Jones","year":"1994","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.21.4.581","article-title":"The antimalarial drug mefloquine binds to membrane phospholipids","volume":"21","author":"Chevli","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0167-4889(84)90007-7","article-title":"On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drug","volume":"803","author":"San George","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(09)70320-2","article-title":"Pharmacogenetics of antimalarial drugs: effect on metabolism and transport","volume":"9","author":"Kerb","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13318-011-0047-8","article-title":"Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum","volume":"3","author":"Milner","year":"2011","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1475-2875-10-150","article-title":"Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice","volume":"10","author":"Dow","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0100","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.bjp.0705721","article-title":"Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice","volume":"141","author":"Barraud de Lagerie","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0105","first-page":"58","article-title":"Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria","volume":"37","author":"Pham","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-642-14541-4_6","article-title":"P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations","volume":"201","author":"Cascorbi","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0304-4165(00)00160-4","article-title":"Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT","volume":"1524","author":"Pham","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00008571-200311000-00001","article-title":"Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers","volume":"13","author":"Skarke","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1213\/01.ane.0000228861.80314.22","article-title":"The pronociceptive effect of ondansetron in the setting of Pglycoprotein inhibition","volume":"103","author":"Scott","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0130","first-page":"397","article-title":"Quinine toxicity when given with doxycycline and mefloquine","volume":"25","author":"Karbwang","year":"1994","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0135","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.biopsych.2011.07.026","article-title":"Mefloquine Blockade of Connexin 36 and Connexin 43 Gap junctions and risk of suicide","volume":"71","author":"Nevin","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clpt.2006.07.003","article-title":"MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine","volume":"80","author":"Aarnoudse","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clineuro.2012.02.046_bib0145","first-page":"583","article-title":"Polymorphism at the MDR1 locus as a cause of mefloquine-induced psychosis","volume":"149","author":"Zaigraykina","year":"2010","journal-title":"Harefuah"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846712001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846712001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T09:46:21Z","timestamp":1742723181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846712001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0303846712001400"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2012.02.046","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}